December 2025 in “International Journal of Research in Dermatology” In this survey, dermatologists in India reported preferring alcohol-free minoxidil combined with procapil and finasteride over traditional alcohol-based formulations for managing androgenetic alopecia, citing better tolerance and patient adherence.
January 2023 in “International Journal of Trichology” This review discusses the positioning of low alcohol or alcohol-free topical minoxidil for managing androgenetic alopecia in Indian clinical practice and reports no new clinical results.
February 2024 in “International Journal of Research in Dermatology” In this study, alcohol-free minoxidil 5% demonstrated effectiveness in improving hair growth parameters and demonstrated a good safety profile and high patient acceptance among Indian men with androgenetic alopecia over 180 days, without any reported adverse events.
1 citations
,
June 2021 in “International journal of pharmaceutical compounding” This study found that compounded minoxidil solutions in a propylene glycol-free and alcohol-reduced foam remained stable for 180 days, meeting United States Pharmacopeia standards for strength, pH, and antimicrobial effectiveness.
31 citations
,
July 2022 in “Advanced healthcare materials/Advanced Healthcare Materials” In this study, researchers developed a drug-free microneedle patch using chitosan lactate and stem cell-derived exosomes that significantly promotes hair regeneration in animal tests compared to minoxidil, highlighting its potential as a simple and efficient hair loss treatment.